Evidence map›Paper›PMID 41144090›Full record

ArticleJournal of robotic surgery2025

Evaluating short- and long-term clinical outcomes of robotic rectal cancer surgery: a comparison of da Vinci S and Xi systems.

A López-Huerta, M L Reyes-Díaz, M A Bonilla-Cozar, F A Domínguez-González, I Ramallo-Solís, G Anguiano-Díaz, J Pintor-Tortolero, A M Garcia-Cabrera, J M Vazquez-Monchul, F De la Portilla and 2 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. [Applying Robot-Assisted Single-Port Laparoscopic Surgery in Gynecology: Technological Paradigm Innovations and Clinical Advances].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

A López-Huerta *Department of Surgery, Hospital Universitario Virgen del Rocío, Seville, Spain.
M L Reyes-Díaz *Department of Surgery, Hospital Universitario Virgen del Rocío, Seville, Spain.
M A Bonilla-CozarDepartment of Surgery, Hospital Universitario Virgen del Rocío, Seville, Spain.
F A Domínguez-GonzálezDepartment of Surgery, Hospital Universitario Virgen del Rocío, Seville, Spain.
I Ramallo-SolísDepartment of Surgery, Hospital Universitario Virgen del Rocío, Seville, Spain.
G Anguiano-DíazDepartment of Surgery, Hospital Universitario Virgen del Rocío, Seville, Spain.
J Pintor-TortoleroDepartment of Surgery, Hospital Universitario Virgen del Rocío, Seville, Spain.
A M Garcia-CabreraDepartment of Surgery, Hospital Universitario Virgen del Rocío, Seville, Spain.
J M Vazquez-MonchulDepartment of Surgery, Hospital Universitario Virgen del Rocío, Seville, Spain.
F De la PortillaDepartment of Surgery, Hospital Universitario Virgen del Rocío, Seville, Spain.
J PadilloDepartment of Surgery, Hospital Universitario Virgen del Rocío, Seville, Spain.
R M Jimenez-RodriguezDepartment of Surgery, Hospital Universitario Virgen del Rocío, Seville, Spain. ros_j_r@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) is the third most common cancer. Rectal cancer accounts for over 30% of CRC cases, presenting surgical challenges owing to its anatomical location. Robotic surgery, has been developed to address these challenges. The da Vinci® Surgical System is widely used in robotic-assisted rectal cancer surgery. This study aims to compare the short and long-term outcomes of rectal cancer surgeries performed using the da Vinci S and Xi systems. A retrospective cohort study was conducted on 284 rectal cancer patients operated with da Vinci robotic systems at tertiary hospital. The da Vinci S (IS2000) was used from January 2008 to April 2018, and the da Vinci Xi (IS4000) from April 2018 to November 2021. Clinical and pathological variables were recorded. Long-term variables were analysed in both groups. Demographic data showed no significant differences in age, sex, or preoperative ASA scores between the groups. Significant differences were found in preoperative anemia and comorbidity index, higher in the Xi system group. Intraoperative analysis indicated shorter setup and operative times with the Xi system, although it had higher rates of intraoperative complications and diverting ileostomy formation. Postoperative complication rate was higher in the Xi group although length of stay was shorter in this group. The median follow-up was 93.6 months. At 5 years, local recurrence rate was 8.2% in the da Vinci S group and 6.6% in the da Vinci Xi group (HR 0.80, 95% CI [0.30-2.18], P = 0.7), while disease-free survival was 78.4% and 78.9%, respectively (HR 1.04, 95% CI [0.58-1.84], P = 0.9), and overall survival was 64.9% in the da Vinci S group and 86.8% in the da Vinci Xi group (HR 0.54, 95% CI [0.27-1.07], P = 0.07). Patients treated with the da Vinci S and da Vinci Xi systems showed similar postoperative outcomes, but the da Vinci Xi system demonstrates superior overall survival. This suggests that the advanced platform may improve surgical precision and patient recovery, potentially enhancing long-term survival.

Indexed as

Rectal NeoplasmsRobotic Surgical ProceduresAdultAgedFemaleHumansLength of StayMaleMiddle AgedOperative TimePostoperative ComplicationsRetrospective StudiesTime FactorsTreatment Outcomeda Vinci systemRectal cancerRobotic surgerySurgical outcomes

Identifiers

PMID41144090

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.